Michael L. Hall

POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS FOR BASILIXIMAB IN KIDNEY TRANSPLANTATION

John M. Kovarik, Barry D. Kahan, P. R. Rajagopalan et al. · Transplantation · 1999 · 90 citations

Medicine, Pharmacokinetics, Pharmacology +14

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Philip Schoenfeld, Brian E. Lacy, William D. Chey et al. · The American Journal of Gastroenterology · 2017 · 75 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A prospective economic evaluation of basiliximab (Simulect®) therapy following renal transplantation

Marc I. Lorber, John Fastenau, David J. Wilson et al. · Clinical Transplantation · 2000 · 40 citations

Pharmacy, Immunology, Pharmacoeconomics +17

Assessing the Benefits of Preoperative Thoracic Epidural Placement for Lung Transplantation

Sean R. McLean, Peter von Homeyer, Aaron M. Cheng et al. · Journal of Cardiothoracic and Vascular Anesthesia · 2018 · 35 citations

Medicine, Anesthesiology, Surgery +13

Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors

Laura Mulloy, Francis H. Wright, Michael L. Hall et al. · Transplantation Proceedings · 1999 · 34 citations

Life Sciences, Immunology, Nephrology +13